{"generic":"Sodium Chloride","drugs":["4-Way Saline Moisturizing Mist","AK-NaCl","Altamist","Ayr","Muro-128","Ocean","SalJet","Sodium Chloride","Syrex"],"mono":{"0":{"id":"555890-s-0","title":"Generic Names","mono":"Sodium Chloride"},"1":{"id":"555890-s-1","title":"Dosing and Indications","sub":{"0":{"id":"555890-s-1-4","title":"Adult Dosing","mono":"<ul><li>(IV) treatment of hypovolemic hyponatremia, the use of hypertonic (3%) saline is seldom indicated and isotonic saline should NOT be administered (guideline dosing)<\/li><li><b>Hyponatremia:<\/b> dose should be guided by serum sodium levels, clinical condition, patient age and weight<\/li><li><b>Hyponatremia:<\/b> chronic hyponatremia, severe symptoms: increase serum sodium by 2 to 4 mmol\/L within 2 to 4 hr (1 to 2 mmol\/L\/hr) with infusion of hypertonic saline; limit corrections of sodium level to less than 10 to 12 mmol\/L in 24 hours, and to less than 18 mmol\/L in 48 hours to avoid demyelination syndrome (guideline dosing)<\/li><li><b>Plasma aldosterone level:<\/b> Intravenous doses used have included: 2-3 L of normal saline IV infused over 4 to 6 hr,  1.25 L of normal saline IV over 2 hr, or 2 L normal saline IV over 4 hr<\/li><li><b>Saline suppression test:<\/b> 2-3 L of normal saline IV infused at 500 mL\/hr over 4-6 hr<\/li><\/ul>"},"3":{"id":"555890-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Corneal edema<\/li><li>Elective termination of pregnancy<\/li><li>Heat stroke<\/li><li>Hyponatremia<\/li><li>Hypovolemic shock<\/li><li>Nasal irritation<\/li><\/ul><b>Non-FDA Labeled Indications<\/b><ul><li>Bronchoscopy and bronchoalveolar lavage - Irrigation of nasal sinus<\/li><li>Cystic fibrosis<\/li><li>Diabetes insipidus; Diagnosis<\/li><li>Flushing cannula<\/li><li>Operative procedure on coronary artery<\/li><li>Plasma aldosterone level<\/li><li>Raised intracranial pressure<\/li><li>Saline suppression test<\/li><\/ul>"}}},"3":{"id":"555890-s-3","title":"Contraindications\/Warnings","sub":[{"id":"555890-s-3-9","title":"Contraindications","mono":"specific contraindications have not been determined <br\/>"},{"id":"555890-s-3-10","title":"Precautions","mono":"<ul><li>cardiac insufficiency; increased risk of sodium retention, requires regular monitoring of fluid status in patients receiving 3% to 5% sodium chloride injection<\/li><li>edema with sodium retention, preexisting; potential worsening of clinical condition<\/li><li>hypertonic solution; may cause vein damage<\/li><li>renal function, impaired; increased risk of sodium retention, severe dysfunction requires regular monitoring of fluid status in patients receiving 3% to 5% sodium chloride injection<\/li><\/ul>"},{"id":"555890-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"555890-s-3-12","title":"Breast Feeding","mono":"<ul><li>WHO: Compatible with breastfeeding.<\/li><li>Micromedex: Infant risk is minimal.<\/li><\/ul>"}]},"5":{"id":"555890-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Cardiovascular:<\/b>Phlebitis<\/li><li><b>Dermatologic:<\/b>Injection site extravasation, Injection site reaction<\/li><li><b>Endocrine metabolic:<\/b>Hypervolemia<\/li><\/ul><b>Serious<\/b><ul><li><b>Cardiovascular:<\/b>Congestive heart failure<\/li><li><b>Endocrine metabolic:<\/b>Hypernatremia, Overhydration<\/li><li><b>Hematologic:<\/b>Disseminated intravascular coagulation<\/li><li><b>Respiratory:<\/b>Respiratory distress<\/li><\/ul>"},"6":{"id":"555890-s-6","title":"Drug Name Info","sub":{"0":{"id":"555890-s-6-17","title":"US Trade Names","mono":"<ul><li>Ayr<\/li><li>Ocean<\/li><li>SalJet<\/li><li>Muro-128<\/li><li>4-Way Saline Moisturizing Mist<\/li><li>AK-NaCl<\/li><li>Altamist<\/li><li>Syrex<\/li><\/ul>"},"2":{"id":"555890-s-6-19","title":"Class","mono":"<ul><li>Antiasthma<\/li><li>Dermatological Agent<\/li><li>Dressing Agent<\/li><li>Eye Wash<\/li><li>Irrigant<\/li><li>Moisturizer<\/li><li>Nasal Agent<\/li><li>Nutriceutical<\/li><li>Osmotherapy Agent<\/li><li>Parenteral Electrolyte, Sodium<\/li><li>Respiratory Agent<\/li><li>Sodium Supplement<\/li><li>Wound Care Agent<\/li><\/ul>"},"3":{"id":"555890-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"555890-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"555890-s-7","title":"Mechanism Of Action","mono":"Sodium chloride is a source of water and electrolyte. Sodium is the principle cation of extracellular fluid and chloride is the principle anion of extracellular fluid.  Sodium content normally determines the volume of extracellular fluid, and important in the regulation of osmolarity, acid-base balance, and the membrane potential of cells.<br\/>"},"10":{"id":"555890-s-10","title":"Monitoring","mono":"<ul><li>adequate hydration and electrolytes is indicative of efficacy<\/li><li>changes in fluid balance, electrolyte concentrations, and acid-base balance, especially during prolonged parenteral therapy.<\/li><\/ul>"},"11":{"id":"555890-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/><ul><li>Inhalation Solution: 0.9 %, 3 %, 7 %, 10 %<\/li><li>Injection Solution: 0.9 %<\/li><li>Intravenous Solution: 0.45 %, 0.9 %, 2.5 %, 3 %, 5 %, 14.6 %, 23.4 %<\/li><li>Irrigation Solution: 0.45 %, 0.9 %<\/li><li>Irrigation Spray: 0.9 %<\/li><li>Nasal Solution: 0.65 %<\/li><li>Nasal Spray: 0.65 %<\/li><li>Ophthalmic Ointment: 5 %<\/li><li>Ophthalmic Solution: 5 %<\/li><li>Oral Tablet: 1 GM<\/li><li>Sublingual Tablet: 6 X, 12 X, 30 X<\/li><\/ul><\/li><li><b>Altamist<\/b><br\/>Nasal Spray: 0.85 %<br\/><\/li><li><b>Ayr Allergy and Sinus<\/b><br\/>Nasal Spray: 2.65 %<br\/><\/li><li><b>Ayr Baby Saline<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Ayr Saline Mist<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Ayr Saline<\/b><br\/>Nasal Solution: 0.65 %<br\/><\/li><li><b>BD PosiFlush<\/b><br\/>Injection Solution: 0.9 %<br\/><\/li><li><b>BD PosiFlush SF<\/b><br\/>Intravenous Solution: 0.9 %<br\/><\/li><li><b>Breathe Free<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Broncho Saline<\/b><br\/>Inhalation Solution: 0.9 %<br\/><\/li><li><b>Curity Sterile Saline<\/b><br\/>Irrigation Solution: 0.9 %<br\/><\/li><li><b>Deep Sea<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Entsol<\/b><br\/>Nasal Spray: 3 %<br\/><\/li><li><b>Entsol Single Use<\/b><br\/>Nasal Solution: 3 %<br\/><\/li><li><b>Good Neighbor Pharmacy Nasal Moisturizing Spray<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Good Neighbor Pharmacy Saline Nasal Spray<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Good Sense Nasal Moisturizing<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Humist<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>HyperSal<\/b><br\/>Inhalation Solution: 3.5 %, 7 %<br\/><\/li><li><b>Kendall Sodium Chloride Flush Syringe<\/b><br\/>Intravenous Solution: 0.9 %<br\/><\/li><li><b>Monoject Prefill Advanced<\/b><br\/>Intravenous Solution: 0.9 %<br\/><\/li><li><b>Monoject Prefill Sodium Chloride<\/b><br\/>Intravenous Solution: 0.9 %<br\/><\/li><li><b>Monoject Sodium Chloride Flush Syringe<\/b><br\/>Intravenous Solution: 0.9 %<br\/><\/li><li><b>Muro-128<\/b><br\/><ul><li>Ophthalmic Ointment: 5 %<\/li><li>Ophthalmic Solution: 2 %, 5 %<\/li><\/ul><\/li><li><b>Mycinaire<\/b><br\/>Nasal Spray: 0.69 %<br\/><\/li><li><b>Nasal Moist<\/b><br\/>Topical Gel\/Jelly: 0.65 %<br\/><\/li><li><b>Natrum Mur<\/b><br\/>Oral Tablet: 6 X<br\/><\/li><li><b>Na-Zone<\/b><br\/>Nasal Spray: 0.75 %<br\/><\/li><li><b>NebuSal<\/b><br\/>Inhalation Solution: 3 %, 6 %<br\/><\/li><li><b>Neti Rinse<\/b><br\/>Nasal Powder for Solution: 2.5 GM\/Packet<br\/><\/li><li><b>Ocean for Kids Premium Saline<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Ocean<\/b><br\/>Nasal Solution: 0.65 %<br\/><\/li><li><b>Ocean Premium Saline<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Ocean Saline Nasal Spray<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>OcuFresh Eye Shower<\/b><br\/>Ophthalmic Solution: 9 MG\/ML<br\/><\/li><li><b>OcuFresh Eye Wash<\/b><br\/>Ophthalmic Solution: 9 MG\/ML<br\/><\/li><li><b>PulmoSal (pH+)<\/b><br\/>Inhalation Solution: 7 %<br\/><\/li><li><b>Rhinaris Mist<\/b><br\/>Nasal Spray: 0.2 %<br\/><\/li><li><b>Rhinaris<\/b><br\/>Nasal Gel\/Jelly: 0.2 %<br\/><\/li><li><b>Rite Aid Eye Care<\/b><br\/>Ophthalmic Solution: 5 %<br\/><\/li><li><b>Rite Aid First Aid Saline Wound Wash<\/b><br\/>Irrigation Solution: 0.9 %<br\/><\/li><li><b>Saline Solution<\/b><br\/>Inhalation Solution: 0.45 %, 0.9 %<br\/><\/li><li><b>SalJet<\/b><br\/>Irrigation Solution: 0.9 %<br\/><\/li><li><b>Saljet Rinse<\/b><br\/>Irrigation Solution: 0.9 %<br\/><\/li><li><b>Sea Mist<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Sea Soft Mist<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Simply Saline<\/b><br\/>Nasal Spray: 0.9 %<br\/><\/li><li><b>Sochlor<\/b><br\/><ul><li>Ophthalmic Ointment: 5 %<\/li><li>Ophthalmic Solution: 5 %<\/li><\/ul><\/li><li><b>Sodium Chloride Freeflex<\/b><br\/>Intravenous Solution: 0.9 %<br\/><\/li><li><b>Sterile Saline Diluent Tip-Lok Syringe<\/b><br\/>Injection Solution: 0.9 %<br\/><\/li><li><b>Syrex<\/b><br\/><ul><li>Injection Solution: 0.9 %<\/li><li>Intravenous Solution: 0.9 %<\/li><\/ul><\/li><li><b>TopCare Nasal Moisturizing Spray<\/b><br\/>Nasal Spray: 0.65 %<br\/><\/li><li><b>Vasceze Sodium Chloride<\/b><br\/>Intravenous Solution: 0.9 %<br\/><\/li><\/ul>"},"12":{"id":"555890-s-12","title":"Toxicology","sub":[{"id":"555890-s-12-31","title":"Clinical Effects","mono":"<b>SODIUM CHLORIDE <\/b><br\/>USES: Used therapeutically as a parenteral crystalloid substitute for volume replacement or for maintenance therapy in the hospital setting. Also, commonly used as an additive for meals (ie, table salt) for electrolyte replacement during sports or outdoor activity, in water softening solutions, and in road salt for deicing roads. EPIDEMIOLOGY: Exposure is common, serious toxicity is very rare. PHARMACOLOGY: Sodium chloride can lead to increases in intravascular volume by adrenal glandular hormonal action. Also, potentially attenuates nitric oxide production. TOXICOLOGY: Sodium chloride can cause direct irritation to mucosal membranes, if ingested and may cause hypernatremia and hyperchloremia. OVERDOSE: MILD TO MODERATE TOXICITY: Nausea, vomiting, diarrhea and abdominal discomfort may develop. Patients may complain of excessive thirst. SEVERE TOXICITY: Restlessness, seizures, mental status depression, coma, tachycardia, fever, hypotension, and respiratory arrest are rare effects of severe sodium chloride toxicity. Acute ulcerative gastritis has been reported. Hypernatremia and hyperchloremia may develop, with associated fluid retention, and the potential for pulmonary and cerebral edema can occur. Hyperosmolarity of cerebral fluids may lead to cellular crenation and irreversible neurologic damage. PEDIATRIC: Poisoning from sodium chloride has resulted from gastric lavage with hypertonic saline and errors in the formulation of infant feeds. Intentional pediatric salt poisonings have been reported. Infants with hypernatremia may develop a flat anterior fontanelle. <br\/>"},{"id":"555890-s-12-32","title":"Treatment","mono":"<b>SODIUM CHLORIDE <\/b><br\/><ul><li>Support: MANAGEMENT OF MILD TO MODERATE TOXICITY: Dilute with milk or water. MANAGEMENT OF SEVERE TOXICITY: Treat hypernatremia with an IV solution containing 30 to 50 mEq\/L sodium. Longstanding hypernatremia should be corrected slowly. Treat seizures with benzodiazepines. Treat cerebral edema with mannitol. Hemodialysis should be performed in patients with severe toxicity.<\/li><li>Decontamination: DILUTION: Immediately dilute with 4 to 8 ounces (120 to 240 mL) of water (not to exceed 4 ounces (120 mL) in a child). OCULAR EXPOSURE: Irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. If irritation, pain swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.<\/li><li>Airway management: Airway management is unlikely to be necessary unless severe toxicity occurs.  Maintain airway patency and adequate oxygenation. Endotracheal intubation and assisted mechanical ventilation may be required.<\/li><li>Hypernatremia: For longstanding hypernatremia, intravenous administration of a solution containing 30 to 50 mEq\/L of sodium (half as chloride and half as bicarbonate) should be administered slowly. The rate of administration is critical (usually 2\/3 of a daily maintenance) and should proceed to lower serum sodium to normal range no sooner than 24 to 36 hours after institution of therapy. If a decrease in serum sodium occurs more rapidly, seizures are likely to ensue. For acute, severe hypernatremia secondary to acute ingestion of large amounts of sodium chloride, more rapid correction of serum sodium with intravenous D5W or other hypotonic solutions, oral free water, or hemodialysis may be appropriate.<\/li><li>Seizure: Administer a benzodiazepine IV. Diazepam: Adult: 5 mg to 10 mg, repeat every 10 to 15 min as needed. CHILD: 0.2 to 0.5 mg\/kg, repeat every 5 minutes as needed OR lorazepam: Adult: 2 to 4 mg; Child: 0.05 to 0.1 mg\/kg. Consider phenobarbital or propofol if seizures recur after diazepam 30 mg (adults) or 10 mg (children older than 5 years). Monitor for hypotension, dysrhythmias, respiratory depression, and need for endotracheal intubation. Monitor for hypoglycemia, electrolyte disturbances and hypoxia.<\/li><li>Hypotensive episode: Infuse 10 to 20 mL\/kg isotonic fluid. If hypotension persists, administer dopamine (5 to 20 mcg\/kg\/min) or norepinephrine (Adult: Begin infusion at 0.5 to 1 mcg\/min; Child: Begin infusion at 0.1 mcg\/kg\/min); titrate to desired response.<\/li><li>Cerebral edema: Monitor intracranial pressure. IV mannitol (0.5 to 1 g\/kg) may be administered to remove excess intracellular water from the brain.<\/li><li>Monitoring of patient: Monitor vital signs and mental status. Monitor serum electrolytes frequently. Monitor renal function and urine output. Urinary sodium excretion will be high in all cases of hypernatremia and cannot be used to differentiate salt poisoning from dehydration. Monitor for evidence of volume overload, pulmonary edema and cerebral edema.<\/li><li>Enhanced elimination procedure: Hemodialysis can effectively remove sodium chloride. It should be considered early in patients with severe hypernatremia or severe clinical manifestations, and in patients with renal insufficiency.<\/li><li>Patient disposition: HOME CRITERIA: Asymptomatic patients with ingestions of less than 8 mEq\/kg (0.5 g\/kg) sodium chloride can probably be managed at home. OBSERVATION CRITERIA: Symptomatic patients, those with deliberate ingestions, and patients ingesting 8 mEq\/kg (0.5 g\/kg) sodium chloride or more should be referred to a healthcare facility. ADMISSION CRITERIA: All patients with evidence of systemic toxicity from sodium chloride, severe hypernatremia not responding to hydration, or those with intractable vomiting should be admitted. CONSULT CRITERIA: Consult a medical toxicologist or poison center for patients with severe hypernatremia or severe clinical manifestations.<\/li><\/ul>"},{"id":"555890-s-12-33","title":"Range of Toxicity","mono":"<b>SODIUM CHLORIDE <\/b><br\/>TOXICITY: Ingestion of 0.5 to 1 g\/kg (8.6 to 17.2 mEq\/kg) of sodium chloride is probably toxic in the majority of patients. Central nervous system signs and symptoms are common with serum sodium concentrations above 150 to 160 mEq\/L. At such levels, there is a 10% chance of seizures which increases when serum sodium concentration reaches 160 to 185 mEq\/L.  Death is a frequent occurrence at serum sodium concentrations above 185 mEq\/L. A teenager survived a serum sodium concentration of 196 mmol\/L following the ingestion of soy sauce (quart size bottle; equivalent to 160 to 170 g salt) following aggressive supportive care; no permanent sequelae occurred. PEDIATRIC: One level tablespoon (17.85 g) is approximately 305 mEq of sodium, and if retained, would raise serum levels by 30.5 mEq\/L in a 3-year-old (15 kg) child. A toddler died after ingesting 400 mEq\/kg and an adolescent died after absorbing an estimated 45 g sodium chloride as salt water. RECOMMENDED DAILY CONSUMPTION: ADULT: It is recommended an adult consume no more than 2300 mg of sodium daily. <br\/>"}]}}}